XML 84 R67.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock-based Compensation - Award Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Exercisable and Expected to Vest      
Options exercisable (in shares) 2,840,000    
Options vested and expected to vest (in shares) 8,508,000    
Options exercisable (in dollars per share) $ 8.05    
Options vested and expected to vest (in dollars per share) $ 5.27    
Weighted average remaining contractual terms, exercisable options 4 years 6 months    
Weighted average remaining contractual terms, vested and expected to vest options 6 years 2 months 12 days    
Aggregate intrinsic value, exercisable options $ 402    
Aggregate intrinsic value, options vested and expected to vest $ 7,724    
RSAs      
Number of Shares      
Non-vested, beginning of period (in shares) 325,000 181,000 80,000
Granted (in shares) 211,000 277,000 159,000
Vested (in shares) (302,000) (133,000) (58,000)
Non-vested, end of period (in shares) 234,000 325,000 181,000
Weighted Average Grant Date Fair Value Per Share      
Non-vested, beginning of period (in dollars per share) $ 3.48 $ 8.45 $ 17.53
Granted (in dollars per share) 3.32 2.89 7.53
Vested (in dollars per share) 3.31 9.04 18.42
Non-vested, end of period (in dollars per share) $ 3.56 $ 3.48 $ 8.45
RSUs      
Number of Shares      
Non-vested, beginning of period (in shares) 1,020,000 518,000 232,000
Granted (in shares) 1,530,000 1,049,000 518,000
Vested (in shares) (383,000) (204,000) (106,000)
Forfeited/Expired (in shares) (157,000) (343,000) (126,000)
Non-vested, end of period (in shares) 2,010,000 1,020,000 518,000
Weighted Average Grant Date Fair Value Per Share      
Non-vested, beginning of period (in dollars per share) $ 7.66 $ 18.15 $ 21.83
Granted (in dollars per share) 3.08 5.24 17.46
Vested (in dollars per share) 8.96 18.42 21.21
Forfeited/Expired (in dollars per share) 4.66 9.71 19.55
Non-vested, end of period (in dollars per share) $ 4.16 $ 7.66 $ 18.15
PSUs      
Number of Shares      
Non-vested, beginning of period (in shares) 292,000 667,000 128,000
Granted (in shares)     686,000
Vested (in shares) (248,000) (315,000) (107,000)
Forfeited/Expired (in shares) (44,000) (75,000) (40,000)
Other (in shares)   15,000  
Non-vested, end of period (in shares) 0 292,000 667,000
Weighted Average Grant Date Fair Value Per Share      
Non-vested, beginning of period (in dollars per share) $ 7.69 $ 9.41 $ 21.24
Granted (in dollars per share)     9.55
Vested (in dollars per share) 7.69 11.02 20.52
Forfeited/Expired (in dollars per share) 7.69 12.49 19.93
Other (in dollars per share)   25.05  
Non-vested, end of period (in dollars per share) $ 0 $ 7.69 $ 9.41
PBOs      
Number of Shares      
Non-vested, beginning of period (in shares) 1,648,000 1,826,000 1,840,000
Granted (in shares) 0 0 733,000
Forfeited/Expired (in shares) (73,000) (178,000) (747,000)
Non-vested, end of period (in shares) 1,575,000 1,648,000 1,826,000
Weighted Average Grant Date Fair Value Per Share      
Non-vested, beginning of period (in dollars per share) $ 5.64 $ 4.70 $ 4.11
Granted (in dollars per share)     9.89
Forfeited/Expired (in dollars per share) 10.23 9.73 8.29
Non-vested, end of period (in dollars per share) $ 5.43 $ 5.64 $ 4.70
Exercisable and Expected to Vest      
Options exercisable (in shares) 1,575,000    
Options vested and expected to vest (in shares) 1,575,000    
Options exercisable (in dollars per share) $ 10.62    
Options vested and expected to vest (in dollars per share) $ 10.62    
Weighted average remaining contractual terms, exercisable options 3 years 4 months 24 days    
Weighted average remaining contractual terms, vested and expected to vest options 3 years 4 months 24 days    
Aggregate intrinsic value, exercisable options $ 114    
Aggregate intrinsic value, options vested and expected to vest $ 114